Log in to save to my catalogue

The recombinant protein combined vaccine based on the fragment C of tetanus toxin and the cross-reac...

The recombinant protein combined vaccine based on the fragment C of tetanus toxin and the cross-reac...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2483819394

The recombinant protein combined vaccine based on the fragment C of tetanus toxin and the cross-reacting material 197

About this item

Full title

The recombinant protein combined vaccine based on the fragment C of tetanus toxin and the cross-reacting material 197

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

Journal title

Applied microbiology and biotechnology, 2021-02, Vol.105 (4), p.1683-1692

Language

English

Formats

Publication information

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

More information

Scope and Contents

Contents

Diphtheria and tetanus toxoids and acellular pertussis (DTaP) vaccines were widely used since 1940s. The exceptional success of childhood vaccination is undisputed. However, the anti-diphtheria and tetanus antibody will decrease with the increase of age in human body. A boosting vaccine for tetanus and diphtheria in adult is recommended by WHO. Rec...

Alternative Titles

Full title

The recombinant protein combined vaccine based on the fragment C of tetanus toxin and the cross-reacting material 197

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2483819394

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2483819394

Other Identifiers

ISSN

0175-7598

E-ISSN

1432-0614

DOI

10.1007/s00253-021-11139-8

How to access this item